Procaps Group SA
NASDAQ:PROC
Procaps Group SA
NASDAQ:PROC
Price:
1.1
USD
Market Closed
Market Cap:
$124.1m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Procaps Group SA
NASDAQ:PROC
|
LU |
|
T
|
TeamViewer SE
F:TMV1
|
DE |
|
Genex Power Ltd
ASX:GNX
|
AU |
|
Applied Visual Sciences Inc
OTC:APVS
|
US |
|
Global Capital Markets Ltd
BSE:530263
|
IN |
|
S
|
Susco PCL
SET:SUSCO
|
TH |
|
Topchoice Medical Co Inc
SSE:600763
|
CN |
|
Groupe SFPI SA
PAR:SFPI
|
FR |
|
D
|
Directa SIM SpA
F:ZP7
|
IT |
|
M
|
MDxHealth SA
NASDAQ:MDXH
|
BE |
|
Green Landscaping Group AB (publ)
STO:GREEN
|
SE |
|
Boat Rocker Media Inc
TSX:BRMI
|
CA |
Multiples-Based Value
There is not enough data to reliably calculate the multiples-based value of PROC.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
PROC
Multiples-Based Value
Base Case
Not Available
Multiples Across Competitors
PROC Competitors Multiples
Procaps Group SA Competitors
Procaps Group SA Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| LU |
|
Procaps Group SA
NASDAQ:PROC
|
124.1m USD | 0.3 | 2.4 | 6.2 | 9.4 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
837.7B USD | 12.9 | 40.6 | 27.4 | 29.3 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
583.9B USD | 6.2 | 21.8 | 15.1 | 18.6 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4 | 19.3 | 11.5 | 12.9 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
228B GBP | 5.2 | 29.9 | 16.5 | 23.3 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
292.3B USD | 4.5 | 16 | 9.9 | 12.1 | |
| CH |
|
Novartis AG
SIX:NOVN
|
228.6B CHF | 5.3 | 21.2 | 13.1 | 16.9 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1T DKK | 3.3 | 10 | 7.5 | 8.7 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
157.9B USD | 2.5 | 20.3 | 7.8 | 10.4 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
120.2B USD | 2.5 | 17.1 | 7.2 | 8.9 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
